Patents by Inventor Hooman Hafezi

Hooman Hafezi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11197985
    Abstract: A microsensor and method of manufacture for a microsensor, comprising an array of filaments, wherein each filament of the array of filaments comprises a substrate and a conductive layer coupled to the substrate and configured to facilitate analyte detection. Each filament of the array of filaments can further comprise an insulating layer configured to isolate regions defined by the conductive layer for analyte detection, a sensing layer coupled to the conductive layer, configured to enable transduction of an ionic concentration to an electronic voltage, and a selective coating coupled to the sensing layer, configured to facilitate detection of specific target analytes/ions. The microsensor facilitates detection of at least one analyte present in a body fluid of a user interfacing with the microsensor.
    Type: Grant
    Filed: December 17, 2020
    Date of Patent: December 14, 2021
    Assignee: One Drop Biosensor Technologies, LLC
    Inventors: Ashwin Pushpala, Alan Szmodis, Matthew Chapman, Weldon Hall, Scott Miller, Hooman Hafezi
  • Patent number: 11173290
    Abstract: The present invention discloses multiple approaches to preventing the capsule walls and other material from interfering with the performance of an electronic device once the device is activated by surrounding fluid. In accordance with the teachings of the present invention, a miniature ingestible device (MID) may be created using excipients and films. The MID, in accordance with various aspects of the present invention, will have a coating or laminating surrounding an electronic device and separating and isolating the device from the pharmaceutical product or drug within the capsule once the capsule is ingested as well as from the capsule itself as the capsule walls begin to collapse during the disintegration process.
    Type: Grant
    Filed: February 1, 2019
    Date of Patent: November 16, 2021
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Timothy Robertson, Hooman Hafezi, Raymond Schmidt
  • Publication number: 20210338166
    Abstract: Improved ingestible event markers are provided. Aspects of the markers may include the presence of a matrix layer that includes a binder and source of an electron acceptor. Alternatively or in addition to the matrix layer, aspects of the markers may include a large surface area electrode having a surface area that exceeds the surface area of the circuitry of the marker. Aspects further include methods of making and using the ingestible event markers.
    Type: Application
    Filed: May 21, 2021
    Publication date: November 4, 2021
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Patricia Johnson, Raymond Schmidt, Anuj Patel, Kevin Cheng, Kosuke Iwai, Hooman Hafezi
  • Patent number: 11149123
    Abstract: Highly-swellable polymeric films are provided. Aspects also include ingestible compositions that include the highly-swellable polymeric film and an ingestible component. Aspects further include methods of making and using the compositions.
    Type: Grant
    Filed: January 28, 2014
    Date of Patent: October 19, 2021
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Hooman Hafezi, Raymond Schmidt
  • Patent number: 11123532
    Abstract: A microsensor and method of manufacture for a microsensor, comprising an array of filaments, wherein each filament of the array of filaments comprises a substrate and a conductive layer coupled to the substrate and configured to facilitate analyte detection. Each filament of the array of filaments can further comprise an insulating layer configured to isolate regions defined by the conductive layer for analyte detection, a sensing layer coupled to the conductive layer, configured to enable transduction of an ionic concentration to an electronic voltage, and a selective coating coupled to the sensing layer, configured to facilitate detection of specific target analytes/ions. The microsensor facilitates detection of at least one analyte present in a body fluid of a user interfacing with the microsensor.
    Type: Grant
    Filed: May 28, 2020
    Date of Patent: September 21, 2021
    Assignee: ONE DROP BIOSENSOR TECHNOLOGIES, LLC
    Inventors: Ashwin Pushpala, Alan Szmodis, Matthew Chapman, Weldon Hall, Scott Miller, Hooman Hafezi
  • Publication number: 20210273734
    Abstract: An apparatus that includes a partial power source including a first material and a second material, the partial power source configured to generate, upon contact with a conducting medium, a potential difference between the first material and the second material to provide power to a control device, and generate, using the first material and the second material, a current flow within the conducting medium, the current flow including information encoded based on a variable conductance between the first material and the second material.
    Type: Application
    Filed: October 5, 2020
    Publication date: September 2, 2021
    Inventors: Mark ZDEBLICK, Andrew THOMPSON, Aleksandr PIKELNY, Timothy L. ROBERTSON, Hooman HAFEZI
  • Patent number: 11051543
    Abstract: An ingestible compositions includes a first polymer layer, an adhesive layer associated with the first polymer layer, where the adhesive layer includes an adhesive material and is configured to releasably adhere to the first polymer layer, an alginate layer adhered to the adhesive layer, and a second polymer layer associated with the alginate layer and configured to releasably adhere to the alginate layer. Aspects further include methods of making and using the compositions.
    Type: Grant
    Filed: July 21, 2016
    Date of Patent: July 6, 2021
    Assignee: OTSUKA PHARMACEUTICAL CO. LTD.
    Inventors: Raymond Schmidt, Hooman Hafezi, Ai Ling Ching, Patricia Johnson, Anuj Patel, Kevin Cheng, Kosuke Iwai
  • Patent number: 11044024
    Abstract: The system of the present invention includes a conductive element, an electronic component, and a partial power source in the form of dissimilar materials. Upon contact with a conducting fluid, a voltage potential is created and the power source is completed, which activates the system. The electronic component controls the conductance between the dissimilar materials to produce a unique current signature. The system can be used in a variety of different applications, including as components of ingestible identifiers, such as may be found in ingestible event markers, e.g., pharma-informatics enabled pharmaceutical compositions.
    Type: Grant
    Filed: December 18, 2019
    Date of Patent: June 22, 2021
    Assignee: Proteus Digital Health, Inc.
    Inventors: Mark Zdeblick, Timothy Robertson, Aleksandr Pikelny, Hooman Hafezi
  • Publication number: 20210100505
    Abstract: A microsensor and method of manufacture for a microsensor, comprising an array of filaments, wherein each filament of the array of filaments comprises a substrate and a conductive layer coupled to the substrate and configured to facilitate analyte detection. Each filament of the array of filaments can further comprise an insulating layer configured to isolate regions defined by the conductive layer for analyte detection, a sensing layer coupled to the conductive layer, configured to enable transduction of an ionic concentration to an electronic voltage, and a selective coating coupled to the sensing layer, configured to facilitate detection of specific target analytes/ions. The microsensor facilitates detection of at least one analyte present in a body fluid of a user interfacing with the microsensor.
    Type: Application
    Filed: December 17, 2020
    Publication date: April 8, 2021
    Inventors: Ashwin Pushpala, Alan Szmodis, Matthew Chapman, Weldon Hall, Scott Miller, Hooman Hafezi
  • Publication number: 20210100504
    Abstract: A microsensor and method of manufacture for a microsensor, comprising an array of filaments, wherein each filament of the array of filaments comprises a substrate and a conductive layer coupled to the substrate and configured to facilitate analyte detection. Each filament of the array of filaments can further comprise an insulating layer configured to isolate regions defined by the conductive layer for analyte detection, a sensing layer coupled to the conductive layer, configured to enable transduction of an ionic concentration to an electronic voltage, and a selective coating coupled to the sensing layer, configured to facilitate detection of specific target analytes/ions. The microsensor facilitates detection of at least one analyte present in a body fluid of a user interfacing with the microsensor.
    Type: Application
    Filed: December 17, 2020
    Publication date: April 8, 2021
    Inventors: Ashwin Pushpala, Alan Szmodis, Matthew Chapman, Weldon Hall, Scott Miller, Hooman Hafezi
  • Publication number: 20210060319
    Abstract: A pharmaceutical product including a housing that defines a cavity, wherein the cavity stores a pharmaceutical material, and wherein the housing comprises a material configured to dissolve based on contact with a fluid, an ingestible device to encode information in a current signature, wherein the ingestible device is positioned within the housing, and a protective material that encompasses the ingestible device. The ingestible device may be attached to a flexible component, wherein the flexible component is configured to releasably secure the ingestible device within the housing.
    Type: Application
    Filed: April 15, 2020
    Publication date: March 4, 2021
    Inventors: Hooman HAFEZI, Raymond SCHMIDT
  • Publication number: 20200405234
    Abstract: A microsensor and method of manufacture for a microsensor, comprising an array of filaments, wherein each filament of the array of filaments comprises a substrate and a conductive layer coupled to the substrate and configured to facilitate analyte detection. Each filament of the array of filaments can further comprise an insulating layer configured to isolate regions defined by the conductive layer for analyte detection, a sensing layer coupled to the conductive layer, configured to enable transduction of an ionic concentration to an electronic voltage, and a selective coating coupled to the sensing layer, configured to facilitate detection of specific target analytes/ions. The microsensor facilitates detection of at least one analyte present in a body fluid of a user interfacing with the microsensor.
    Type: Application
    Filed: May 28, 2020
    Publication date: December 31, 2020
    Inventors: Ashwin Pushpala, Alan Szmodis, Matthew Chapman, Weldon Hall, Scott Miller, Hooman Hafezi
  • Publication number: 20200359933
    Abstract: Ingestible event markers having high reliability are provided. Aspects of the ingestible event markers include a support, a control circuit, a first electrochemical material, a second electrochemical material and a membrane. In addition, the ingestible event markers may include one or more components that impart high reliability to the ingestible event marker. Further, the ingestible event markers may include an active agent. In some aspects, the active agent, such as a pharmaceutically active agent or a diagnostic agent may be associated with the membrane.
    Type: Application
    Filed: December 16, 2019
    Publication date: November 19, 2020
    Inventors: Hooman HAFEZI, Kit Yee AU-YEUNG, Robert DUCK, Maria HOLEN, Timothy ROBERTSON, Benedict COSTELLO
  • Publication number: 20200260990
    Abstract: The system of the present invention includes a conductive element, an electronic component, and a partial power source in the form of dissimilar materials. Upon contact with a conducting fluid, a voltage potential is created and the power source is completed, which activates the system. The electronic component controls the conductance between the dissimilar materials to produce a unique current signature. The system can also measure the conditions of the environment surrounding the system.
    Type: Application
    Filed: November 20, 2019
    Publication date: August 20, 2020
    Inventors: Jeremy FRANK, Peter BJELETICH, Hooman HAFEZI, Robert AZEVEDO, Robert DUCK, Iliya PESIC, Benedict COSTELLO, Eric SNYDER
  • Patent number: 10653875
    Abstract: A pharmaceutical product including a housing that defines a cavity, wherein the cavity stores a pharmaceutical material, and wherein the housing comprises a material configured to dissolve based on contact with a fluid, an ingestible device to encode information in a current signature, wherein the ingestible device is positioned within the housing, and a protective material that encompasses the ingestible device. The ingestible device may be attached to a flexible component, wherein the flexible component is configured to releasably secure the ingestible device within the housing.
    Type: Grant
    Filed: April 19, 2017
    Date of Patent: May 19, 2020
    Assignee: Proteus Digital Health, Inc.
    Inventors: Hooman Hafezi, Raymond Schmidt
  • Publication number: 20200121220
    Abstract: The system of the present invention includes a conductive element, an electronic component, and a partial power source in the form of dissimilar materials. Upon contact with a conducting fluid, a voltage potential is created and the power source is completed, which activates the system. The electronic component controls the conductance between the dissimilar materials to produce a unique current signature. The system can be used in a variety of different applications, including as components of ingestible identifiers, such as may be found in ingestible event markers, e.g., pharma-informatics enabled pharmaceutical compositions.
    Type: Application
    Filed: December 18, 2019
    Publication date: April 23, 2020
    Inventors: Mark ZDEBLICK, Timothy ROBERTSON, Aleksandr PIKELNY, Hooman HAFEZI
  • Publication number: 20200121902
    Abstract: A microsensor and method of manufacture for a microsensor, comprising an array of filaments, wherein each filament of the array of filaments comprises a substrate and a conductive layer coupled to the substrate and configured to facilitate analyte detection. Each filament of the array of filaments can further comprise an insulating layer configured to isolate regions defined by the conductive layer for analyte detection, a sensing layer coupled to the conductive layer, configured to enable transduction of an ionic concentration to an electronic voltage, and a selective coating coupled to the sensing layer, configured to facilitate detection of specific target analytes/ions. The microsensor facilitates detection of at least one analyte present in a body fluid of a user interfacing with the microsensor.
    Type: Application
    Filed: December 20, 2019
    Publication date: April 23, 2020
    Inventors: Ashwin Pushpala, Alan Szmodis, Matthew Chapman, Weldon Hall, Scott Miller, Hooman Hafezi
  • Publication number: 20200121241
    Abstract: The Breast Sense Feeding Monitor provides real-time measurement of breastfeeding metrics including milk volume and infant suck and swallow characteristics over multiple feedings. The wearable design lends itself to versions suitable for both home and in-clinic use.
    Type: Application
    Filed: September 13, 2017
    Publication date: April 23, 2020
    Inventors: Hooman Hafezi, Mary Judith Insun Feezer, Douglas Alan Webb
  • Patent number: 10610128
    Abstract: A system for administering prescription medications including a composition and a receiver. The composition may include an active agent, an identifier, and a pharmaceutically acceptable carrier. The active agent may include a controlled pharmaceutical. The identifier may include: a partial power source having a first material and a second material configured to generate a voltage in contact with a conductive fluid within a body of a patient, and a signal generation component configured to use at least a portion of the generated voltage to transmit a signal through the body of the patient. The receiver may be positioned near the body of the patient, wherein the receiver is configured to: receive the signal transmitted through the body of the patient, and automatically report the signal for at least one of identification of the controlled pharmaceutical or tracking physical administration of the controlled pharmaceutical to the body of the patient.
    Type: Grant
    Filed: October 20, 2017
    Date of Patent: April 7, 2020
    Assignee: PROTEUS DIGITAL HEALTH, INC.
    Inventors: Mark Zdeblick, Andrew Thompson, Aleksandr Pikelny, Timothy L. Robertson, Hooman Hafezi
  • Patent number: 10588544
    Abstract: Ingestible event markers having high reliability are provided. Aspects of the ingestible event markers include a support, a control circuit, a first electrochemical material, a second electrochemical material and a membrane. In addition, the ingestible event markers may include one or more components that impart high reliability to the ingestible event marker. Further, the ingestible event markers may include an active agent. In some aspects, the active agent, such as a pharmaceutically active agent or a diagnostic agent may be associated with the membrane.
    Type: Grant
    Filed: February 23, 2016
    Date of Patent: March 17, 2020
    Assignee: Proteus Digital Health, Inc.
    Inventors: Hooman Hafezi, Kit Yee Au-Yeung, Robert Duck, Maria Holen, Timothy Robertson, Benedict Costello